AstraZeneca and regulators have said they are studying the blood-clotting matter further and that the benefits of the shot outweigh risks for most people.
The new analysis concludes that the benefits of the AstraZeneca vaccine, along with heightened risks of internal bleeding and blood clots from Covid-19 itself, far outweighed any increased risks from the shot for most people.